LEVOIN; Nicolas

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEVOIN; Nicolas.The latest application filed is for "benzimidazole derivatives as dual histamine h1 and histamine h4 receptor ligands".

Company Profile

2.12.15

LEVOIN; Nicolas - L'HERMITAGE FR
Levoin; Nicolas - Mordelles FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20220281839 - BERREBI-BERTRAND; Isabelle ; et al.	2022-09-08
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands Grant 11,306,069 - Berrebi-Bertrand , et al. April 19, 2	2022-04-19
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20190144421 - BERREBI-BERTRAND; Isabelle ; et al.	2019-05-16
6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands Grant 9,255,101 - Berrebi-Bertrand , et al. February 9, 2	2016-02-09
Benzazole derivatives as histamine H4 receptor ligands Grant 9,029,357 - Berrebi-Bertrand , et al. May 12, 2	2015-05-12
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20150004181 - BERREBI-BERTRAND; Isabelle ; et al.	2015-01-01
Dicarboxylic acid derivatives as S1P1 receptor agonists Grant 8,809,539 - Capet , et al. August 19, 2	2014-08-19
Benzazole derivatives as histamine H4 receptor ligands Grant 8,802,664 - Berrebi-Bertrand , et al. August 12, 2	2014-08-12
Carbonylated (aza) cyclohexanes as dopamine D.sub.3 receptor ligands Grant 8,802,678 - Capet , et al. August 12, 2	2014-08-12
Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications App 20130324507 - BERREBI-BERTRAND; Isabelle ; et al.	2013-12-05
New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands App 20130324506 - BERREBI-BERTRAND; Isabelle ; et al.	2013-12-05
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20130231329 - Berrebi-Bertrand; Isabelle ; et al.	2013-09-05
Histamine H3-receptor ligands and their therapeutic applications Grant 8,076,329 - Bertrand , et al. December 13, 2	2011-12-13
Histamine H.sub.3-receptor ligands and their therapeutic application Grant 8,017,646 - Bertrand , et al. September 13, 2	2011-09-13
Novel Dicarboxylic Acid Derivatives As S1p1 Receptor Agonists App 20100249187 - Capet; Marc ; et al.	2010-09-30
Carbonylated (aza) Cyclohexanes As Dopamine D3 Receptor Ligands App 20090286801 - Capet; Marc ; et al.	2009-11-19
Novel Dicarboxylic Acid Derivatives App 20090264469 - Capet; Marc ; et al.	2009-10-22
Novel Histamine H3-receptor Ligands And Their Therapeutic Applications App 20090111808 - Bertrand; Isabelle ; et al.	2009-04-30
Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents Grant 7,432,269 - Capet , et al. October 7, 2	2008-10-07
Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands App 20080214542 - Capet; Marc ; et al.	2008-09-04
Histamine H3-Receptor Ligands and Their Therapeutic Application App 20080182876 - Bertrand; Isabelle ; et al.	2008-07-31
Novel Arylpiperazine Derivatives App 20080167320 - Capet; Marc ; et al.	2008-07-10
Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents App 20060089364 - Capet; Marc ; et al.	2006-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.